Publicaciones en colaboración con investigadores/as de Universitat de València (239)

2024

  1. Antibiotic resistance and tolerance: What can drug delivery do against this global threat?

    Drug Delivery and Translational Research

  2. Association between Beverage Consumption and Environmental Sustainability in an Adult Population with Metabolic Syndrome

    Nutrients, Vol. 16, Núm. 5

  3. Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model

    Drug Delivery and Translational Research

  4. Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population

    Biomedicines, Vol. 12, Núm. 2

  5. Latest advances in glucose-responsive microneedle-based systems for transdermal insulin delivery

    International Journal of Biological Macromolecules, Vol. 263

2023

  1. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)

    Journal of hypertension, Vol. 41, Núm. 12, pp. 1874-2071

  2. Analysis of microsamples by miniaturized magnetic-based pipette tip microextraction: determination of free cortisol in serum and urine from very low birth weight preterm newborns

    Analyst, Vol. 148, Núm. 5, pp. 1050-1057

  3. Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 861-871

  4. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)

    Leukemia

  5. Corrigendum to “Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer” [Redox Biol. 34 (2020) 101528] (Redox Biology (2020) 34, (S2213231720304882), (10.1016/j.redox.2020.101528))

    Redox Biology

  6. Coupling in vitro food digestion with in vitro epithelial absorption; recommendations for biocompatibility

    Critical Reviews in Food Science and Nutrition

  7. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

  8. Editorial: Innovative pharmacometric approaches to inform drug development and clinical use

    Frontiers in Pharmacology

  9. Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 121

  10. Invariant properties of mycobiont-photobiont networks in Antarctic lichens

    Global Ecology and Biogeography, Vol. 32, Núm. 11, pp. 2033-2046

  11. Perceptions of change in the environment caused by the COVID-19 pandemic: Implications for environmental policy

    Environmental Impact Assessment Review, Vol. 99

  12. Phytotherapeutic alternatives for neurodegenerative dementias: Scientific review, discussion and therapeutic proposal

    Phytotherapy Research, Vol. 37, Núm. 3, pp. 1176-1211

2022

  1. Caffeine, D-glucuronolactone and Taurine Content in Energy Drinks: Exposure and Risk Assessment

    Nutrients, Vol. 14, Núm. 23

  2. Complex effects of Mg-biomaterials on the osteoblast cell machinery: A proteomic study

    Biomaterials Advances, Vol. 137

  3. Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines

    Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 483-494